Altman MK

No ORCID on file · 1 paper in corpus
2010
Molecular cancer ·doi:10.1186/1476-4598-9-140

BackgroundAlthough the incidence of melanoma in the U.S. is rising faster than any other cancer, the FDA-approved chemotherapies lack efficacy for advanced disease, which results in poor overall survival. Lysophosphatidic acid (LPA), autota…